To our best knowledge, this is an innovative investigation linking HuR silencing to oncogene regulation, efflux transporter reversal and apoptosis modulation for improving chemosensitivity of colon cancer cells to antineoplastic agents. Here, ELAVL1 is linked to colonic neoplasm.